September 22, 2021 – Scott Lipkin, DPM, has been appointed vice president and research director for Baptist Health South Florida. Dr Lipkin is responsible for the oversight and executive management of the organization’s research enterprise, including financial administration, grant management, protocol development, human / IRB protection and conformity.
“We are engaging in research, which is more important today than ever, and we are fortunate to have Dr. Lipkin leading this imperative,” said Brian Keeley, CEO of Baptist Health. “Our focus on expanding clinical research and innovation aligns with our mission to provide exceptional care to the communities we are privileged to serve. “
“Dr. Lipkin is dedicated to helping achieve safe research procedures for patients,” said Jack Ziffer, Ph.D., MD, executive vice president, clinical director and general manager of Baptist Health. “In his role Expanded, he will lead efforts to transform the Baptist Health research company into a nationally recognized and strategically aligned business unit. ”
In addition to his new role, Dr. Lipkin will continue to serve as Director of Research at the Miami Cancer Institute, under the leadership of Michael Zinner, MD, CEO of the Institute. In this role, he is responsible for the executive direction of the Miami Cancer Institute’s research program, including clinical operations, research administration, bioreference, academic affiliations, institutional review board, and compliance.
“I am passionate about research and excited about the opportunity to advance research in Baptist Health,” said Dr. Lipkin, who has over 30 years of combined experience as an Executive Research Administrator. , Administrator of the Human Research Protection Program, President Institutional Review Board, Management Consultant, Podiatric Physician and Surgeon, and Clinical Research Investigator. “It is an honor to work with our entire research team to provide the best care and hope for patients and families.
Dr. Lipkin received his Doctor of Podiatric Medicine degree from Temple University School of Podiatric Medicine. He then completed his residency in podiatric surgery and was chief resident at St. Mary’s Hospital in Philadelphia.
He began his career with the medical staff at Lehigh Valley Health Network (LVHN). He was also head of the podiatric surgery division for 10 years. He started participating in clinical research early in his career, as a primary or secondary investigator in numerous clinical trials related to diabetic foot wounds and wound healing.
Dr. Lipkin began to hold research positions while maintaining his clinical practice. He chaired LVHN’s Institutional Review Board and led the organization through national accreditation. He then began serving on national committees and councils focused on research ethics, patient safety and research compliance.
His dedication to the operational and compliance aspect of the clinical research continuum led him to accept a full-time position in administration in 2010. He was head of the research and innovation network office, where he created a centralized research office. In 2014, he moved to research consulting.
Dr Lipkin joined the Miami Cancer Institute after working at Ankura Consulting, where he was Managing Director of Clinical Research and Compliance Practice. In this role, he provided research and compliance related advisory services to academic medical centers, cancer centers, children’s hospitals and major healthcare systems across the United States.
Dr Lipkin is an Assistant Instructor in Loyola University Law School, a member of the IRB Professional Certification Board, and a frequent speaker at professional events and conferences across the country.
About Baptist Health South Florida
Baptist Health South Florida is the region’s largest healthcare organization, with 11 hospitals, over 23,000 employees, 4,000 physicians and 100 outpatient centers, emergency care facilities and physician offices across Miami-Dade, Monroe, Broward and Palm Beach counties. Baptist Health has internationally renowned centers of excellence in cancer, cardiovascular care, orthopedics and sports medicine, and neuroscience. Additionally, it includes Baptist Health Medical Group; Baptist Health Quality Network; and Baptist Health Care On Demand, a virtual health platform. A philanthropy-backed nonprofit committed to its faith-based charitable mission of medical excellence, Baptist Health has been recognized by Fortune as one of the Top 100 Companies to Work for in America and by Ethisphere as the one of the Most ethical companies. For more information visit BaptistHealth.net/Newsroom and connect with us on Facebook, Instagram, Twitter and LinkedIn.